Most patients with MS are diagnosed in early adulthood and live most of their lives with the disease. Various age-related changes can affect the disease course of MS over time. Sex hormones, including estradiol and testosterone, have been found to have neuroprotective effects. These hormones often decrease in patients as they approach their 50s, potentially impacting the disease course in patients with MS.

This episode will feature 3 unique perspectives on the effects of sex-hormone changes and age-related hormonal changes on the MS disease course: Ms. Amy Perrin Ross, an advanced practice nurse specializing in MS; and 2 patients with MS, Mr. Dan Melfi and Ms. Kathey Carr, who will discuss how these age-related hormonal changes have affected their disease and overall quality of life.